Glucocorticoid repression of human with-no-lysine (K) kinase-4 gene expression is mediated by the negative response elements in the promoter

Journal of Molecular Endocrinology

Volumn 40, Issue 1-2, 2008, Pages 3-12

  Li, Chunyi ^a   Li, Yan ^a   Li, Yinghui ^a   Liu, Hong ^a   Sun, Zhijun ^a   Lu, Jingyu ^a   Zhao, Yanyan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LUCIFERASE; PROTEIN KINASE WNK4; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ELECTROLYTE BALANCE; FLUID BALANCE; GEL MOBILITY SHIFT ASSAY; GENE AMPLIFICATION; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; REGULATORY MECHANISM; TRANSCRIPTION INITIATION SITE;

5' FLANKING REGION; ANIMALS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS;

EID: 39549107784     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-07-0049     Document Type: Article

References (23)

1. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E & Haegeman G 2000 Glucocorticoids repress NF-κB-driven genes by 0disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. PNAS 97 3919-3924.
2. Buckingham JC 2006 Glucocorticoids: exemplars of multi-tasking. British Journal of Pharmacology 147 S258-S268.
3. Dickinson H, Walker DW, Wintour EM & Moritz K 2007 Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 292 R453-R461.
4. Drouin J, Sun YL, Chamberland M, Gauthier Y, De Lean A, Nemer M & Schmidt TJ 1993 Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO Journal 12 145-156.
5. Flick MB, Sapi E & Kacinski BM 2002 Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element. Journal of Cellular Biochemistry 8 10-23.
6. Fuller PJ, Lim-Tio SS & Brennan FE 2000 Specificity in mineralocorticoid versus glucocordcoid action. Kidney, International 157 1256-1264.
7. Kahle KT, Wilson FH, Leng Q, Lalioti MD, O'connell AD, Dong K, Rapson AK, MagGregor GG, Giebisch G, Hebert SC et al. 2003 WNK4 regulates the balance between renal NaCl reabsorption and K + secretion. Nature Genetics 35 372-376.
8. Kahle KT, Macgregor GG, Wilson FH, Van Hoek AN, Brown D, Ardito T, Kashgarian M, Giebisch G, Hebert SC, Boulpaep EL et al. 2004 Paracellular Cl permeability, is regulated by WNK4 kinase: insight in to normal physiology and hypertension. PNAS 101 14877-14882.
9. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV & Wingender E 2003 MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Research 31 3576-3579.
10. Li Y, Zhao Y, Li G, Wang J, Li T, Li W & Lu J 2007 Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-κB acetylation in human neuroblastoma cells. Journal of Neurochemistry 101 1194-1204.
11. Malkoski SP & Dorin RI 1999 Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Molecular Endocrinology 13 1629-1644.
12. Meyer T, Gustafsson JA & Carlstedt DJ 1997 Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA and Cell Biology 16 919-927.
13. Oakley RH, Webster JC, Jewell CM, Sar M & Cidlowski JA 1999 Immunocytochemical analysis of the glucocorticoid receptor alpha isoform (GRa) using a GRa-specific antibody. Steroids 64 742-751.
14. Ortiz LA, Quan A, Zarzar F, Weinberg A & Baum M 2003 Prenatal dexamethasone programs hypertension and renal injury in the rat. Hypertension 41 328-334.
15. Ou XM, Storring JM, Kushwaha N & Albert PR 2001 Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. Journal of Biological Chemistry 276 14299-14307.
16. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P & Drouin J 1997 Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Molecular and Cellular Biology 17 5952-5959.
17. Radoja N, Komine M, Jho SH, Blumenberg M & Tomic-Canic M 2000 Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Molecular and Cellular Biology 20 4328-4339.
18. + channel trafficking. Endocrinology 146 5079-5085.
19. Stellato C 2004 Post-transcriptional and nongenomic effects of glucocorticoids. Proceedings of the American Thoracic Society 1 255-263.
20. Wald H, Garty H, Palmer LG & Popovtzer MM 1998 Differential regulation of ROMK expression in kidney cortex and medulla by aldosterone and potassium. American Journal of Physiology, Renal Physiology 275 F239-F245.
21. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM et al. 2001 Human hypertension caused by mutations in WNK kinases. Science 293 1107-1112.
22. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S & Uchida S 2004 Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. PNAS 101 4690-4694.
23. Zhao YY, Zhou J, Narayanan CS, Cui Y & Kumar A 1999 Role of C/A polymorphism at - 20 on the expression of human angiotensinogen gene. Hypertension 33 108-115.